ScreenerHero
GEHCGE HealthCare Technologies Inc. Common Stock
NAS · US · Technology · Medical Devices · gehealthcare.com
73.94USD-0.91%Mkt Cap: 33.94B $P/E: 17.19

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler SE
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
SN
Smith & Nephew plc
$9.73BUSDP/E 19.8
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
DEMANT
Demant A/S
$8.82BUSDP/E 25.0
MASI
Masimo Corporation
$9.42BUSDP/E 44.4

Key Statistics

Company
Market Cap33.94B $
Enterprise Value42.16B $
Revenue (TTM)21.27B $
Gross Profit8.25B $
Net Income (TTM)2.08B $
Revenue/Share46.79 USD
Last Price73.94 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees54.0K
CountryUS
SectorTechnology
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)17.19
P/E (Forward)13.69
PEG2.06
EV/EBITDA11.73
EV/Revenue1.98
P/S1.57
P/B3.05
EPS (TTM)4.31
EPS (Forward)5.41
52W Range
58.7549% of range89.77
52W High89.77 USD
52W Low58.75 USD
Profitability
Gross Margin39.99%
Oper. Margin14.98%
EBITDA Margin16.90%
Profit Margin10.10%
ROE20.08%
ROA5.65%
Growth
Revenue Growth5.80%
Earnings Growth16.80%
Cash Flow & Leverage
Operating CF1.99B $
CapEx (TTM)482.00M $
FCF Margin7.40%
FCF Yield4.63%
Net Debt8.46B $
Net Debt/EBITDA2.36
Balance Sheet
Debt/Equity1.01
Current Ratio1.26
Quick Ratio0.83
Book Value/Sh24.30 USD
Cash/Share4.603 USD
Dividends
Fwd Div Rate0.1400 USD
Trail. Div Rate0.1400 USD
Div. Yield0.19%
5Y Avg Yield—
Payout Ratio3.23%
Ex-Div DateJul 24, 2026
Pay DateAug 14, 2026
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.50 USD
Upside (mean)+11.6%
Target Range70.00 USD – 96.00 USD
$70.00+11.6% to mean$96.00
# Analysts18
Ownership
Shares Out.454.89M
Float450.25M
Insiders0.35%
Institutions94.12%
Short Interest
Short Ratio3.3d
Short % Float4.87%
Short % Out.4.29%
Shares Short19.39M
Short (prev mo.)14.37M
Technical
SMA 5066.43 (+11.3%)
SMA 20072.84 (+1.5%)
Beta0.82
S&P 52W Chg18.16%
Avg Vol (30d)4.69M
Avg Vol (10d)2.62M
Technical Indicators
RSI (14)66.5
MACD2.4789
MACD Signal2.1156
MACD Hist.+0.3633
BB Upper78.53 USD
BB Middle69.19 USD
BB Lower59.85 USD
BB Width27.00%
ATR (14)2.078 USD
Vol Ratio (20d)0.65x